79 related articles for article (PubMed ID: 3820734)
41. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
42. Production of potent immunoglobulins by group A streptococcus for antibody dependent cell-mediated cytotoxicity in mice.
Murayama T; Koshimura S; Natsuume-Sakai S
Jpn J Exp Med; 1985 Dec; 55(6):225-32. PubMed ID: 3915030
[TBL] [Abstract][Full Text] [Related]
43. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
Weinhold KJ; Bolognesi DP; Matthews TJ
J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
[TBL] [Abstract][Full Text] [Related]
44. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
Clark DA; Chaput A; Walker C; Rosenthal KL
J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
[TBL] [Abstract][Full Text] [Related]
45. Enhanced susceptibility of glutaraldehyde-treated tumor cells to antibody-dependent macrophage-mediated cytolysis.
Iwata-Dohi N; Esumi-Kurisu M; Ikenami M; Sadatsune K; Mizuno D; Yamazaki M
Cancer Res; 1982 Aug; 42(8):3196-200. PubMed ID: 6807539
[TBL] [Abstract][Full Text] [Related]
46. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
47. Immunosuppression of T lymphocyte function by fractionated serum from tumor-bearing mice.
McMaster R; Buhler K; Whitney R; Levy JG
J Immunol; 1977 Jan; 118(1):223-5. PubMed ID: 830748
[TBL] [Abstract][Full Text] [Related]
48. Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB; Pyle JM; Dray S
Cancer Immunol Immunother; 1984; 16(3):162-9. PubMed ID: 6561068
[TBL] [Abstract][Full Text] [Related]
49. Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells--in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis.
Mori T; Mori Y; Yoshida H; Ueda S; Ogawa M; Iesato K; Wakashin Y; Wakashin M; Okuda K
Hepatology; 1985; 5(5):770-7. PubMed ID: 4029889
[TBL] [Abstract][Full Text] [Related]
50. [Experimental approach to the investigation of tumor progression].
Okada F; Hamada J; Hasegawa J; Takeichi N; Hosokawa M; Kobayashi H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1210-8. PubMed ID: 2730020
[TBL] [Abstract][Full Text] [Related]
51. Isolation and characterization of canine venereal tumor-associated inhibitory and blocking factors.
Beschorner WE; Hess AD; Nerenberg ST; Epstein RB
Cancer Res; 1979 Oct; 39(10):3920-7. PubMed ID: 476629
[TBL] [Abstract][Full Text] [Related]
52. [Electrokinetic and functional characteristics of natural killers in mice].
Polyntsev DG; Tatulian SA
Tsitologiia; 1987 Sep; 29(9):1041-7. PubMed ID: 3501623
[TBL] [Abstract][Full Text] [Related]
53. Effector cells working for rejection of Ad12 tumors in mice.
Maeta Y; Toshima M; Miura R; Yamai TY; Hamada C
Microbiol Immunol; 1982; 26(12):1139-48. PubMed ID: 6302452
[TBL] [Abstract][Full Text] [Related]
54. Nature of the spleen cell populations capable of releasing tumor enhancing factor.
Eiján AM; Jasnis MA; Kohan SS; Oisgold-Dagá S
J Surg Oncol; 1987 Nov; 36(3):161-5. PubMed ID: 3500369
[TBL] [Abstract][Full Text] [Related]
55. Detection of allogeneic Qa/TL and Ly specificities on murine tumor cells with IgD in tumor-regressor serum.
Tanino T; Seo N; Okazaki T; Nakanishi-Ito C; Sekimata M; Egawa K
Cancer Immunol Immunother; 1992; 35(4):230-6. PubMed ID: 1380893
[TBL] [Abstract][Full Text] [Related]
56. [Cytotoxic antibodies in the serum of C3H mice after inoculating them with spontaneous mammary gland tumor cells].
Lavrovskiĭ VA; Viksler VKh
Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):57-61. PubMed ID: 227196
[TBL] [Abstract][Full Text] [Related]
57. The induction of immunity against tumor cell transplantation with a complex of tumor cell surface substance and a serum component found in the tumor-regressor animals.
Egawa K; Tanino T
Int J Cancer; 1976 Jun; 17(6):725-9. PubMed ID: 947852
[TBL] [Abstract][Full Text] [Related]
58. Experimental systemic amyloidosis induced by immunization with syngeneic organ extracts in mice.
Mori Y; Akikusa B; Mori T; Ueda S; Iesato K; Yoshida H; Ogawa M; Kato I; Wakashin Y; Wakashin M
J Exp Med; 1986 Jun; 163(6):1553-65. PubMed ID: 3519830
[TBL] [Abstract][Full Text] [Related]
59. Quantitative studies of the sensitivity of normal and neoplastic mouse cells to the cytotoxic action of isoantibodies.
MOLLER E; MOLLER G
J Exp Med; 1962 Mar; 115(3):527-53. PubMed ID: 14475217
[TBL] [Abstract][Full Text] [Related]
60. Factors in the sera of tumor-bearing mice modifying the charge of immune cells.
Vaillier D; Vaillier J
Int Arch Allergy Appl Immunol; 1983 Mar; 70(3):207-12. PubMed ID: 6600712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
